Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

TRAILBLAZER-ALZ 4: Topline study results directly comparing donanemab to aducanumab on amyloid lowering in early, symptomatic Alzheimer’s disease

Author:Salloway, Stephen   Lee, Elly   Papka, Michelle   Pain, Andrew   Oru, Ena   Ferguson, Margaret   Wang, Hong   Case, Michael   Lu, Ming   Collins, Emily   Brooks, Dawn   Sims, John   

Session Name:S26: Experimental Therapeutics in Dementia  

Topic:Aging and Dementia  

Program Number:S26.009  

Author Institution:Brown Medical School, Providence, RI  Irvine Clinical Research, Irvine, CA  The Cognitive and Research Center of New Jersey LLC, Springfield, NJ  Eli Lilly and Company, Indianapolis, IN  

Decentralized approaches in TRAILBLAZER-ALZ 3

Author:Yaari, Roy   Holdridge, Karen   Ferguson, Margaret   Wessels, Alette   Sims, John   

Session Name:P7: Aging and Dementia: Therapeutics 1  

Topic:Aging and Dementia  

Program Number:P7.006  

Author Institution:Eli Lilly and Company, Indianapolis, IN  Banner Alzheimer’s Institute, Phoenix, AZ  Cogstate Ltd, Melbourne, Australia  Irvine Clinical Research, Irvine, CA